Re:23andMe to share customer gene data with GlaxoSmithKline ...
by take_a_breath on Wednesday December 18, 2019 @10:50AM
(#21826048)
And I was responding to this comment: "if I buy some shares in Amazon I don't get have all their client data."
The point is that GSK wouldn't have invested $300 million without the exclusive collaboration agreement. That is why it's different than buying a publicly traded stock. GSK is not just a random shareholder, they are a significant owner (may even have board seats) with an exclusive collaboration agreement. You are splitting those things up to make your argument, but they are linked together.
The point is that GSK wouldn't have invested $300 million without the exclusive collaboration agreement. That is why it's different than buying a publicly traded stock. GSK is not just a random shareholder, they are a significant owner (may even have board seats) with an exclusive collaboration agreement. You are splitting those things up to make your argument, but they are linked together.